Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleContinuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date18/10/2
    PersonsYoungWan Kim, Junyong Park
View all 1
View less